Phil Felgner

University of California, Irvine

Papers

1

Total Citations

21

H-Index

1

About

Phil Felgner is a pioneering figure in molecular immunology and vaccine development, best known for his foundational work in protein microarray technology. His research has revolutionized the field of antigen discovery, particularly for parasitic diseases, enabling high-throughput screening of immune responses. Felgner’s major contributions include the development of whole-proteome microarrays, which allow researchers to map antibody responses to thousands of proteins simultaneously. This innovation has been instrumental in identifying vaccine targets for pathogens such as malaria, tuberculosis, and HIV. His most-cited paper, “Protein Microarrays for Parasite Antigen Discovery” (2014, with over 21 citations), exemplifies his impact, though his broader body of work has garnered thousands of citations, reflecting its influence on global health. Felgner’s achievements extend to co-founding Antigen Discovery Inc., a company translating his research into diagnostic and vaccine tools. His work has been recognized with numerous awards, including the NIH Director’s Pioneer Award, and he continues to shape the future of infectious disease research.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Protein Microarrays for Parasite Antigen Discovery
21 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: University of California, Irvine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago